Bruker ’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and its ongoing portfolio transformation. Yet, the company’s operations face the wrath of excessive ...

It offers new possibilities in subcellular proteomics. Bruker also introduced the neofleX MALDI-TOF/TOF multiomic Mass Spec Imaging Benchtop system, which is set to enable multiomic colocalization ...

Researchers at the University of Oxford and their collaborators, including the Serum Institute of India, have developed an innovative method to identify falsified vaccines without opening the vaccine ...

Nucleic Acid Fragmentation Test Standard (8217028, Bruker) was used for instrument calibration before ... urea-denaturing PAGE, and MALDI-TOF MS, establishing that RT is a bifunctional enzyme.

Integration with Bruker’s MALDI Imaging methods enable multimodal imaging to characterize tissues with enhanced analytical depth. The LUMOS II ILIM can also be used for rapid pharmaceutical ...

Bruker Corporation announced the launch of the LUMOS™ II ILIM , a quantum cascade laser (QCL) based infrared imaging microscope. The new LUMOS II ILIM redefines performance standards, enabling pharma ...

Bruker Corporation (NASDAQ: BRKR) is undervalued, trading below its fair value of $74, offering significant upside potential due to its strategic acquisitions and improving book value per share ...

Reaction products with different degrees of functionalization were analyzed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Additional gradient elution ...